Simple Plans

AI in Life Sciences: Real-Time Competitive Intelligence Subscriptions

Simple Plans

AI in Life Sciences: Real-Time Competitive Intelligence Subscriptions

Simple Plans

AI in Life Sciences: Real-Time Competitive Intelligence Subscriptions

Feature Image
Feature Image
Feature Image

AI in Life Science Competitive Intelligence Subscription

Whats Included In the Subscription

Checklist
Emerging AI Use Cases in Clinical, Regulatory & R&D

Checklist
Global Regulatory Trends: EMA, FDA, PMDA, and AI Act Signals

Checklist
Competitive Benchmarks Across 15+ Life Science Innovators

Checklist
Monthly Forecasts Through 2035 — Driven by Market + CI Modeling

Checklist
Forecasts to 2034 — backed by CI modeling

AI in Life Science Competitive Intelligence Subscription

Whats Included In the Subscription

Checklist
Emerging AI Use Cases in Clinical, Regulatory & R&D

Checklist
Global Regulatory Trends: EMA, FDA, PMDA, and AI Act Signals

Checklist
Competitive Benchmarks Across 15+ Life Science Innovators

Checklist
Monthly Forecasts Through 2035 — Driven by Market + CI Modeling

Checklist
Forecasts to 2034 — backed by CI modeling

AI in Life Science Competitive Intelligence Subscription

Whats Included In the Subscription

Checklist
Emerging AI Use Cases in Clinical, Regulatory & R&D

Checklist
Global Regulatory Trends: EMA, FDA, PMDA, and AI Act Signals

Checklist
Competitive Benchmarks Across 15+ Life Science Innovators

Checklist
Monthly Forecasts Through 2035 — Driven by Market + CI Modeling

Checklist
Forecasts to 2034 — backed by CI modeling

Why This Subscription Matters: Actionable AI Intelligence for Life Sciences

The AI in Life Science Competitive Intelligence Subscription delivers unmatched strategic clarity in a fast-moving, high-stakes space. Each month, we decode market signals, competitor benchmarks, and global regulatory shifts so you can make confident, data-backed decisions. You’ll get a clear view of what’s working, what’s failing, and where your organization stands in relation to your peers. Unlike one-off reports, this subscription evolves with the field — layering fresh insight atop a rigorous CI foundation. Our proprietary scoring maps cut through noise and let you see strategic risks and readiness at a glance. Forecasts are backed by real adoption signals, not speculation. This is the only subscription built to guide AI strategy inside life sciences, not just report on it.

Why This Subscription Matters: Actionable AI Intelligence for Life Sciences

The AI in Life Science Competitive Intelligence Subscription delivers unmatched strategic clarity in a fast-moving, high-stakes space. Each month, we decode market signals, competitor benchmarks, and global regulatory shifts so you can make confident, data-backed decisions. You’ll get a clear view of what’s working, what’s failing, and where your organization stands in relation to your peers. Unlike one-off reports, this subscription evolves with the field — layering fresh insight atop a rigorous CI foundation. Our proprietary scoring maps cut through noise and let you see strategic risks and readiness at a glance. Forecasts are backed by real adoption signals, not speculation. This is the only subscription built to guide AI strategy inside life sciences, not just report on it.

Why This Subscription Matters: Actionable AI Intelligence for Life Sciences

The AI in Life Science Competitive Intelligence Subscription delivers unmatched strategic clarity in a fast-moving, high-stakes space. Each month, we decode market signals, competitor benchmarks, and global regulatory shifts so you can make confident, data-backed decisions. You’ll get a clear view of what’s working, what’s failing, and where your organization stands in relation to your peers. Unlike one-off reports, this subscription evolves with the field — layering fresh insight atop a rigorous CI foundation. Our proprietary scoring maps cut through noise and let you see strategic risks and readiness at a glance. Forecasts are backed by real adoption signals, not speculation. This is the only subscription built to guide AI strategy inside life sciences, not just report on it.

Emerging AI Use Cases

Get monthly insights on how AI is reshaping Clinical Development, Regulatory Affairs, and R&D decision-making. Includes implementation lessons and workflow innovations.

Emerging AI Use Cases

Get monthly insights on how AI is reshaping Clinical Development, Regulatory Affairs, and R&D decision-making. Includes implementation lessons and workflow innovations.

Emerging AI Use Cases

Get monthly insights on how AI is reshaping Clinical Development, Regulatory Affairs, and R&D decision-making. Includes implementation lessons and workflow innovations.

Features Icon
Global Regulatory Signals

Track evolving AI compliance guidance from the EMA, FDA, PMDA, and EU AI Act. Early alerts and contextual analysis help you stay ahead.

Features Icon
Global Regulatory Signals

Track evolving AI compliance guidance from the EMA, FDA, PMDA, and EU AI Act. Early alerts and contextual analysis help you stay ahead.

Features Icon
Global Regulatory Signals

Track evolving AI compliance guidance from the EMA, FDA, PMDA, and EU AI Act. Early alerts and contextual analysis help you stay ahead.

Competitor Benchmarks & Adoption Trends

Compare adoption progress across 15+ life science innovators — from pharma to digital therapeutics. Includes maturity models and investment patterns.

Competitor Benchmarks & Adoption Trends

Compare adoption progress across 15+ life science innovators — from pharma to digital therapeutics. Includes maturity models and investment patterns.

Competitor Benchmarks & Adoption Trends

Compare adoption progress across 15+ life science innovators — from pharma to digital therapeutics. Includes maturity models and investment patterns.

Features Icon
Strategic Risk, ROI & Readiness Maps

Sector-specific scoring tools to assess where AI investment is paying off — and where risk mitigation is still needed.

Features Icon
Strategic Risk, ROI & Readiness Maps

Sector-specific scoring tools to assess where AI investment is paying off — and where risk mitigation is still needed.

Features Icon
Strategic Risk, ROI & Readiness Maps

Sector-specific scoring tools to assess where AI investment is paying off — and where risk mitigation is still needed.

Features Icon
Forecasts Through 2035 — CI-Driven

Forward-looking opportunity and disruption forecasts powered by competitive intelligence modeling.

Features Icon
Forecasts Through 2035 — CI-Driven

Forward-looking opportunity and disruption forecasts powered by competitive intelligence modeling.

Features Icon
Forecasts Through 2035 — CI-Driven

Forward-looking opportunity and disruption forecasts powered by competitive intelligence modeling.

Pipeline Insights + Decision Support Tools

Access CI-backed snapshots that track AI-enabled trial acceleration, data harmonization, and pipeline impact across major therapeutic areas

Pipeline Insights + Decision Support Tools

Access CI-backed snapshots that track AI-enabled trial acceleration, data harmonization, and pipeline impact across major therapeutic areas

Pipeline Insights + Decision Support Tools

Access CI-backed snapshots that track AI-enabled trial acceleration, data harmonization, and pipeline impact across major therapeutic areas

Choose the subscription tier that matches your strategic needs — from quick insights to deep-dive analysis. Our CI service delivers timely, actionable intelligence focused on AI trends, regulatory shifts, and competitor positioning in life sciences. Flexible options. No clutter. Just insight that drives results.
Foundations £95

European/UK/Non-EU-based early startups & strategy team. - Monthly summary slides - 1 past report excerpt - Visual trends (no consultation) - Email insights digest

Insight £500

Small team exploration, useful for early validation. - Access to 1–2 standard reports/month - Curated infographics & data visuals - Monthly industry newsletter - Email-only support

Foundations £95

European/UK/Non-EU-based early startups & strategy team. - Monthly summary slides - 1 past report excerpt - Visual trends (no consultation) - Email insights digest

Insight £500

Small team exploration, useful for early validation. - Access to 1–2 standard reports/month - Curated infographics & data visuals - Monthly industry newsletter - Email-only support

Foundations £95

European/UK/Non-EU-based early startups & strategy team. - Monthly summary slides - 1 past report excerpt - Visual trends (no consultation) - Email insights digest

Professional £1500

Mid-size orgs needing regular insights & benchmarking. Full access to monthly CI briefs, Interactive trend dashboards, Quarterly live analyst webinars,Response-time guaranteed support.

Insight £500

Small team exploration, useful for early validation. - Access to 1–2 standard reports/month - Curated infographics & data visuals - Monthly industry newsletter - Email-only support

Professional £1500

Mid-size orgs needing regular insights & benchmarking. Full access to monthly CI briefs, Interactive trend dashboards, Quarterly live analyst webinars,Response-time guaranteed support.

Insight £500

Small team exploration, useful for early validation. - Access to 1–2 standard reports/month - Curated infographics & data visuals - Monthly industry newsletter - Email-only support

Premium
Micro Tier

Scale-ups & mid-size orgs needing strategic CI. Tailored monthly CI + competitive forecast. 1–2 strategy consults/mth. Exec-ready briefings & tools. Partial integration to internal workflows.

For solo consultants and curious strategists who want a high-level view of AI safety in life sciences — no extras, just clarity.

Enterprise

Large organizations needing real-time, high-touch CI. - Fully embedded CI function - Unlimited insights + bespoke tracking - Predictive analytics + modeling - Dedicated advisor & CI team access.

Enterprise

Large organizations needing real-time, high-touch CI. - Fully embedded CI function - Unlimited insights + bespoke tracking - Predictive analytics + modeling - Dedicated advisor & CI team access.

Premium

Scale-ups and mid-size orgs needing strategic CI. - Tailored monthly CI + competitive forecast - 1–2 strategy consults/month - Exec-ready briefings & tools - Partial integration to internal workflows.

Premium

Scale-ups and mid-size orgs needing strategic CI. - Tailored monthly CI + competitive forecast - 1–2 strategy consults/month - Exec-ready briefings & tools - Partial integration to internal workflows.

Compare Between Plans

Our pricing table is best viewed on a desktop device. Please visit this page on a desktop browser to see a complete comparison of all subscription tiers and features.

FAQs

Frequently Asked Questions

FAQs

Frequently Asked Questions

FAQs

Frequently Asked Questions

How is this different from enterprise platforms like AlphaSense or Cortellis?

Enterprise platforms provide self-service database access—you search and analyze yourself. We provide analyst-driven strategic intelligence—human experts who deliver insights and recommendations specific to your needs. Think of us as your fractional CI team, not a software subscription.

What’s shifting in the landscape — and why should I care now?

Because timing matters. We track not just competitor actions, but the strategic meaning behind them.

How do you gather competitive intelligence?

We analyze publicly available sources including ClinicalTrials.gov, regulatory databases, scientific publications, company press releases, investor presentations, and conference proceedings. All work is conducted ethically and legally. We never use corporate espionage or questionable methods.

Can I use these reports in investor materials?

Yes. The reports are yours to use as you see fit—in pitch decks, board presentations, or strategic planning documents. We can also format deliverables to match your investor deck style upon request.

What if my competitors are private companies with limited information?

We specialize in piecing together intelligence from fragmentary sources. Even private biotechs leave digital footprints through trial registries, publications, patents, job postings, and conference presentations. This is where analyst expertise matters—connecting the dots that platforms miss.

How long does it take to get a competitive intelligence report?

One-time reports: 2 weeks from kickoff to final delivery, including a 60-minute strategy debrief call. Free competitive briefs: 3-5 business days. Monthly subscriptions: Initial setup takes 1-2 weeks, then you receive ongoing briefings on your chosen schedule (weekly, bi-weekly, or monthly). We prioritize speed without sacrificing quality—perfect for biotech teams working against tight timelines.

What if I'm not sure which service I need?

Start with our free 1-page competitive brief. This gives you a taste of our analysis style and helps us understand your specific needs. Based on that initial brief, we can recommend whether a one-time report, monthly subscription, or custom project makes the most sense for your situation. No pressure, no obligation—we'd rather recommend the right fit than oversell.

Do you work with companies outside the UK?

Yes, we have operations in UK & US. We work with biotech companies globally—UK, EU, US, Canada, and beyond. Our intelligence coverage is international (we track FDA, EMA, PMDA, and other regulatory bodies), and we deliver reports remotely via video calls and digital documents. Time zone differences are never an issue—we schedule debriefs at times that work for your team.

How is this different from enterprise platforms like AlphaSense or Cortellis?

Enterprise platforms provide self-service database access—you search and analyze yourself. We provide analyst-driven strategic intelligence—human experts who deliver insights and recommendations specific to your needs. Think of us as your fractional CI team, not a software subscription.

What’s shifting in the landscape — and why should I care now?

Because timing matters. We track not just competitor actions, but the strategic meaning behind them.

How do you gather competitive intelligence?

We analyze publicly available sources including ClinicalTrials.gov, regulatory databases, scientific publications, company press releases, investor presentations, and conference proceedings. All work is conducted ethically and legally. We never use corporate espionage or questionable methods.

Can I use these reports in investor materials?

Yes. The reports are yours to use as you see fit—in pitch decks, board presentations, or strategic planning documents. We can also format deliverables to match your investor deck style upon request.

What if my competitors are private companies with limited information?

We specialize in piecing together intelligence from fragmentary sources. Even private biotechs leave digital footprints through trial registries, publications, patents, job postings, and conference presentations. This is where analyst expertise matters—connecting the dots that platforms miss.

How long does it take to get a competitive intelligence report?

One-time reports: 2 weeks from kickoff to final delivery, including a 60-minute strategy debrief call. Free competitive briefs: 3-5 business days. Monthly subscriptions: Initial setup takes 1-2 weeks, then you receive ongoing briefings on your chosen schedule (weekly, bi-weekly, or monthly). We prioritize speed without sacrificing quality—perfect for biotech teams working against tight timelines.

What if I'm not sure which service I need?

Start with our free 1-page competitive brief. This gives you a taste of our analysis style and helps us understand your specific needs. Based on that initial brief, we can recommend whether a one-time report, monthly subscription, or custom project makes the most sense for your situation. No pressure, no obligation—we'd rather recommend the right fit than oversell.

Do you work with companies outside the UK?

Yes, we have operations in UK & US. We work with biotech companies globally—UK, EU, US, Canada, and beyond. Our intelligence coverage is international (we track FDA, EMA, PMDA, and other regulatory bodies), and we deliver reports remotely via video calls and digital documents. Time zone differences are never an issue—we schedule debriefs at times that work for your team.

How is this different from enterprise platforms like AlphaSense or Cortellis?

Enterprise platforms provide self-service database access—you search and analyze yourself. We provide analyst-driven strategic intelligence—human experts who deliver insights and recommendations specific to your needs. Think of us as your fractional CI team, not a software subscription.

What’s shifting in the landscape — and why should I care now?

Because timing matters. We track not just competitor actions, but the strategic meaning behind them.

How do you gather competitive intelligence?

We analyze publicly available sources including ClinicalTrials.gov, regulatory databases, scientific publications, company press releases, investor presentations, and conference proceedings. All work is conducted ethically and legally. We never use corporate espionage or questionable methods.

Can I use these reports in investor materials?

Yes. The reports are yours to use as you see fit—in pitch decks, board presentations, or strategic planning documents. We can also format deliverables to match your investor deck style upon request.

What if my competitors are private companies with limited information?

We specialize in piecing together intelligence from fragmentary sources. Even private biotechs leave digital footprints through trial registries, publications, patents, job postings, and conference presentations. This is where analyst expertise matters—connecting the dots that platforms miss.

How long does it take to get a competitive intelligence report?

One-time reports: 2 weeks from kickoff to final delivery, including a 60-minute strategy debrief call. Free competitive briefs: 3-5 business days. Monthly subscriptions: Initial setup takes 1-2 weeks, then you receive ongoing briefings on your chosen schedule (weekly, bi-weekly, or monthly). We prioritize speed without sacrificing quality—perfect for biotech teams working against tight timelines.

What if I'm not sure which service I need?

Start with our free 1-page competitive brief. This gives you a taste of our analysis style and helps us understand your specific needs. Based on that initial brief, we can recommend whether a one-time report, monthly subscription, or custom project makes the most sense for your situation. No pressure, no obligation—we'd rather recommend the right fit than oversell.

Do you work with companies outside the UK?

Yes, we have operations in UK & US. We work with biotech companies globally—UK, EU, US, Canada, and beyond. Our intelligence coverage is international (we track FDA, EMA, PMDA, and other regulatory bodies), and we deliver reports remotely via video calls and digital documents. Time zone differences are never an issue—we schedule debriefs at times that work for your team.

Regulatory Advisory

Cta Shape

Get Started

Ready To Gain An Edge On A Volatile Life Science Landscape

AI in Safety Compliance Competitive Intelligence Report

Cta Image
Cta Image
Cta Shape

Get Started

Ready To Gain An Edge On A Volatile Life Science Landscape

AI in Safety Compliance Competitive Intelligence Report

Cta Image
Cta Image

Get Started

Ready To Gain An Edge On A Volatile Life Science Landscape

AI in Safety Compliance Competitive Intelligence Report

Cta Image
Cta Image